Rapid enrollment is supported by “No patients – No Payment” initiative, which means that the client reimburses Cromos Pharma only for enrolled patients and not for dormant, non-recruiting sites.
We believe in delivering efficient patient recruitment starting at the site level. This means selecting the right sites and working with them to maximize enrollment potential. We communicate closely with them to plan and manage local activities from translating protocols to designing effective pre-screening strategies to identify the right patients. This approach has resulted in an unparalleled track record in patient recruitment whereby our team met or shortened project timelines in 95% of conducted trials.
Our experienced feasibility team will swiftly prepare a detailed capability / feasibility report. It will propose the optimal path forward, including country/venue strategy- and site-selection within the recommended venues. We offer free feasibility reports for Sponsors considering locating their trials in Central and Eastern Europe.
More than half of all studies fail to meet enrollment timelines. If your study is behind schedule or encounters difficulties with recruitment/retention of subjects, Cromos Pharma can provide a comprehensive and collaborative rescue plan to ensure original investments yield a return and that the study is conducted efficiently. We offer the most rational and economical rescue plans to Sponsors to ensure the best value proposition at every stage of drug development.
Our team of experts has years of experience successfully working with the FDA, EMA, and all relevant regulatory authorities across our regions. This in-depth local knowledge of submission guidelines and algorithms means that, depending upon the selected countries, your study will be up and running within 8-20 weeks.
The welfare of our patients is our first priority. We are fully compliant with ICH-GCP and make sure that patients in our studies are well-informed, and have a direct line of communication to both the investigators and to our research team. Our multilingual Patient Portal provides relevant educational materials about clinical trials and patients’ rights.
Our Quality Management System is built upon Quality by Design principles that include integrated planning, quality agreements tailored to each project, real-time project risk-based analysis, data analytics-driven targeted monitoring, and customer-focused project optimization.
Cromos Pharma is a US based international clinical research organization (CRO) delivering fully integrated clinical research solutions in all trial phases, across a wide range of therapeutic areas.
Cromos Pharma is driven by our goal to provide clients with the highest quality services and to exceed their expectations.
Cromos Pharma leadership team brings together professionals with extensive industry experience dedicated to delivering clinical trials success.
Cromos Pharma strives to attract the best and the brightest talent to join us in our mission to accelerate drug development.